For patients with disease recurrence post-SRS, an increasingly frequent scenario given the rise in BM incidence, the ideal treatment approach remains unclear [10]
While AOD-9604 with GLP-1 agonists is an area of interest, adding more compounds to an already complex dual-peptide protocol increases variables and makes troubleshooting more difficult
(6) Such findings might reflect an increase in somatotroph cell populationsthe specialized pituitary cells primarily associated with synthesizing and releasing growth hormone
Convenience We understand that life can be hectic, which is why we go the extra mile to ensure accessing quality care is as convenient as possible
Ischemic stroke In a rat embolic-stroke model, thymosin beta-4 given 24 hours after middle-cerebral-artery occlusion improved neurological outcome, with benefits detectable as early as 14 days
In a rat model of focal cerebral ischemia, 3-AB reduced lesion volumes and attenuated NMDA-induced neurotransmitter dysregulation 173
